rspНаучно-практическая ревматологияRheumatology Science and Practice1995-44841995-4492IMA-PRESS, LLC10.47360/1995-4484-2025-549-551rsp-3830Research ArticleСтатьиArticlesНобелевская премия 2025: Т-регуляторные клеткиNobel Prize 2025: Regulatory T cellshttps://orcid.org/0000-0002-1598-8360НасоновЕ. Л.NasonovE. L.

115522, Москва, Каширское шоссе, 34а

Evgeny L. Nasonov

115522, Moscow, Kashirskoye Highway, 34A

nasonov@irramn.ruhttps://orcid.org/0000-0002-1865-4251РубцовЮ. П.RubtsovYu. P.

117997, Москва, ул. Миклухо-Маклая, 16/10

Yuri P. Rubtsov

117997, Moscow, Miklukho-Maklaya str., 16/10

https://orcid.org/0000-0003-3057-9175АвдееваА. С.AvdeevaA. S.

115522, Москва, Каширское шоссе, 34а

Anastasia S. Avdeeva

115522, Moscow, Kashirskoye Highway, 34A

ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»РоссияV.A. Nasonova Research Institute of RheumatologyRussian FederationФГБУ Государственный научный центр Российской Федерации Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАНРоссияShemyakin – Ovchinnikov Institute of Bioorganic ChemistryRussian Federation202530122025636549551Copyright © Насонов Е.Л., Рубцов Ю.П., Авдеева А.С., 20252025Насонов Е.Л., Рубцов Ю.П., Авдеева А.С.Nasonov E.L., Rubtsov Y.P., Avdeeva A.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://rsp.mediar-press.net/rsp/article/view/3830

.

.

ReferencesOfford C. Research on immune system’s ‘police’ garners Nobel. Science. 2025;390(6769):112-113. doi: 10.1126/science.aec9015Offord C. Research on immune system’s ‘police’ garners Nobel. Science. 2025;390(6769):112-113. doi: 10.1126/science.aec9015Shi P, Yu Y, Xie H, Yin X, Chen X, Zhao Y, et al. Recent advances in regulatory immune cells: exploring the world beyond Tregs. Front Immunol. 2025;16:1530301. doi: 10.3389/fimmu.2025.1530301Shi P, Yu Y, Xie H, Yin X, Chen X, Zhao Y, et al. Recent advances in regulatory immune cells: exploring the world beyond Tregs. Front Immunol. 2025;16:1530301. doi: 10.3389/fimmu.2025.1530301Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155(3):1151-1164.Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155(3):1151-1164.Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001;27(1):68-73. doi: 10.1038/83784Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001;27(1):68-73. doi: 10.1038/83784Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 2001;27(1):18-20. doi: 10.1038/83707Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 2001;27(1):18-20. doi: 10.1038/83707Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27(1):20-21. doi: 10.1038/83713Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27(1):20-21. doi: 10.1038/83713Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299(5609):1057-1061. doi: 10.1126/science.1079490Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299(5609):1057-1061. doi: 10.1126/science.1079490Wing JB, Tanaka A, Sakaguchi S. Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity. 2019;50(2):302-316. doi: 10.1016/j.immuni.2019.01.020Wing JB, Tanaka A, Sakaguchi S. Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity. 2019;50(2):302-316. doi: 10.1016/j.immuni.2019.01.020Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, Stroud JC, et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell. 2006;126(2):375-387. doi: 10.1016/j.cell.2006.05.042Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, Stroud JC, et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell. 2006;126(2):375-387. doi: 10.1016/j.cell.2006.05.042Zhang R, Miao J, Zhu P. Regulatory T cell heterogeneity and therapy in autoimmune diseases. Autoimmun Rev. 2021;20(5):102715. doi: 10.1016/j.autrev.2020.102715Zhang R, Miao J, Zhu P. Regulatory T cell heterogeneity and therapy in autoimmune diseases. Autoimmun Rev. 2021;20(5):102715. doi: 10.1016/j.autrev.2020.102715Khan A, Roy P, Ley K. Breaking tolerance: The autoimmune aspect of atherosclerosis. Nat Rev Immunol. 2024;24(9):670-679. doi: 10.1038/s41577-024-01010-yKhan A, Roy P, Ley K. Breaking tolerance: The autoimmune aspect of atherosclerosis. Nat Rev Immunol. 2024;24(9):670-679. doi: 10.1038/s41577-024-01010-yWang L, Liang Y, Zhao C, Ma P, Zeng S, Ju D, et al. Regulatory T cells in homeostasis and disease: Molecular mechanisms and therapeutic potential. Signal Transduct Target Ther. 2025;10(1):345. doi: 10.1038/s41392-025-02326-4Wang L, Liang Y, Zhao C, Ma P, Zeng S, Ju D, et al. Regulatory T cells in homeostasis and disease: Molecular mechanisms and therapeutic potential. Signal Transduct Target Ther. 2025;10(1):345. doi: 10.1038/s41392-025-02326-4Raffin C, Vo LT, Bluestone JA. Treg cell-based therapies: Challenges and perspectives. Nat Rev Immunol. 2020;20(3):158-172. doi: 10.1038/s41577-019-0232-6Raffin C, Vo LT, Bluestone JA. Treg cell-based therapies: Challenges and perspectives. Nat Rev Immunol. 2020;20(3):158-172. doi: 10.1038/s41577-019-0232-6Wright RC, Campbell DJ, Levings MK. Pharmacotherapeutic strategies to promote regulatory T cell function in autoimmunity. Curr Opin Immunol. 2025;94:102554. doi: 10.1016/j.coi.2025.102554Wright RC, Campbell DJ, Levings MK. Pharmacotherapeutic strategies to promote regulatory T cell function in autoimmunity. Curr Opin Immunol. 2025;94:102554. doi: 10.1016/j.coi.2025.102554Rudensky AY. Regulatory T cells and Foxp3. Immunol Rev. 2011;241(1):260-268. doi: 10.1111/j.1600-065X.2011.01018.xRudensky AY. Regulatory T cells and Foxp3. Immunol Rev. 2011;241(1):260-268. doi: 10.1111/j.1600-065X.2011.01018.xHu W, Wang ZM, Feng Y, Schizas M, Hoyos BE, van der Veeken J, et al. Regulatory T cells function in established systemic inflammation and reverse fatal autoimmunity. Nat Immunol. 2021;22(9):1163-1174. doi: 10.1038/s41590-021-01001-4Hu W, Wang ZM, Feng Y, Schizas M, Hoyos BE, van der Veeken J, et al. Regulatory T cells function in established systemic inflammation and reverse fatal autoimmunity. Nat Immunol. 2021;22(9):1163-1174. doi: 10.1038/s41590-021-01001-4Avdeeva A, Rubtsov Y, Dyikanov D, Popkova T, Nasonov E. Regulatory T cells in patients with early untreated rheumatoid arthritis: Phenotypic changes in the course of methotrexate treatment. Biochimie. 2020;174:9-17. doi: 10.1016/j.biochi.2020.03.014Avdeeva A, Rubtsov Y, Dyikanov D, Popkova T, Nasonov E. Regulatory T cells in patients with early untreated rheumatoid arthritis: Phenotypic changes in the course of methotrexate treatment. Biochimie. 2020;174:9-17. doi: 10.1016/j.biochi.2020.03.014Насонов ЕЛ, Александрова ЕН, Авдеева АС, Рубцов ЮП. Т-регуляторные клетки при ревматоидном артрите. Научнопрактическая ревматология. 2014;52(4):430-437. doi: 10.14412/1995-4484-2014-430-437Nasonov EL, Aleksandrova EN, Avdeeva AS, Rubtsov YuP. T-regulatory cells in rheumatoid arthritis. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2014;52(4):430-437 (In Russ.). doi: 10.14412/1995-4484-2014-430-437Авдеева АС, Рубцов ЮП, Дыйканов ДТ, Насонов ЕЛ. Клинико-патогенетическое значение Foxр3+ регуляторных Т-клеток при ревматоидном артрите. Научно-практическая ревматология. 2016;54(4):442-455. doi: 10.14412/1995-44842016-442-455Avdeeva AS, Rubtsov YuP, Dyikanov DT, Nasonov EL. The clinical and pathogenetic value of Foxp3+ T regulatory cells in rheumatoid arthritis. NauchnoPrakticheskaya Revmatologia = Rheumatology Science and Practice. 2016;54(4):442-455 (In Russ.). doi: 10.14412/1995-44842016-442-455Быковская СН, Насонов ЕЛ. Роль дефектов иммуносупрессии в развитии аутоиммунных заболеваний. Научно-практическая ревматология. 2005;(4):81-84. doi: 10.14412/1995-4484-2005-623Bykovskaya SN, Nasonov EL. Role of immune suppression defects in the development of autoimmune diseases. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2005;43(4):81-84 (In Russ.). doi: 10.14412/1995-4484-2005-623Lyssuk EY, Torgashina AV, Soloviev SK, Nassonov EL, Bykovskaia SN. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol. 2007;601:113-119.Lyssuk EY, Torgashina AV, Soloviev SK, Nassonov EL, Bykovskaia SN. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol. 2007;601:113-119.

The authors declare that there are no conflicts of interest present.